Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants.
作者信息
Esteve-Pastor María Asunción, García-Fernández Amaya, Roldán Vanessa, Marín Francisco
机构信息
Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, El Palmar, Murcia, Spain.
Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica ISABIAL-FISABIO, Alicante, Spain.
出版信息
Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):132-133. doi: 10.1016/j.rec.2016.11.006. Epub 2016 Dec 27.
PMID:28034682
Abstract
摘要
相似文献
1
Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants.接受口服抗凝剂治疗的非瓣膜性心房颤动患者的HAS - BLED和ORBIT出血风险评分评估
Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):132-133. doi: 10.1016/j.rec.2016.11.006. Epub 2016 Dec 27.
2
Increasing Use of Anticoagulants in Germany and Its Impact on Hospitalization for Intracranial Bleeding.德国抗凝剂使用的增加及其对颅内出血住院治疗的影响。
Circ Cardiovasc Qual Outcomes. 2018 May;11(5):e004470. doi: 10.1161/CIRCOUTCOMES.117.004470.
3
Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study.心房颤动患者的大出血和颅内出血风险预测：关注可改变的出血风险因素还是使用出血风险分层评分？一项全国性队列研究。
Int J Cardiol. 2018 Mar 1;254:157-161. doi: 10.1016/j.ijcard.2017.11.025. Epub 2018 Jan 28.
4
Comparison of the CHADS-VASc, CHADS, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non-Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation.CHADS-VASc、CHADS、HAS-BLED、ORBIT和ATRIA风险评分在预测心房颤动患者非维生素K拮抗剂口服抗凝药相关出血中的比较
Am J Cardiol. 2017 Nov 1;120(9):1549-1556. doi: 10.1016/j.amjcard.2017.07.051. Epub 2017 Jul 31.
5
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.ORBIT出血评分：一种用于评估房颤出血风险的简单床旁评分。
Eur Heart J. 2015 Dec 7;36(46):3258-64. doi: 10.1093/eurheartj/ehv476. Epub 2015 Sep 29.
6
Intracranial hemorrhage with target specific oral anticoagulants in patients with atrial fibrillation: An updated meta-analysis of randomized controlled trials.心房颤动患者使用靶向特异性口服抗凝剂后的颅内出血：随机对照试验的最新荟萃分析
Int J Cardiol. 2016 Jan 15;203:1000-2. doi: 10.1016/j.ijcard.2015.11.097. Epub 2015 Nov 17.
7
Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation.仅基于可修正风险因素的出血风险评估与房颤中经验证的出血风险评分比较。
Am J Med. 2018 Feb;131(2):185-192. doi: 10.1016/j.amjmed.2017.09.009. Epub 2017 Sep 21.
8
Performance of the HAS-BLED, ORBIT, and ATRIA Bleeding Risk Scores on a Cohort of 399 344 Hospitalized Patients With Atrial Fibrillation and Cancer: Data From the French National Hospital Discharge Database.HAS-BLED、ORBIT 和 ATRIA 出血风险评分在 399344 例住院房颤合并癌症患者队列中的表现：来自法国国家住院患者数据库的数据。
J Am Heart Assoc. 2022 Dec 6;11(23):e026388. doi: 10.1161/JAHA.121.026388. Epub 2022 Nov 29.
9
Delayed Intracranial Hemorrhage after Blunt Head Trauma while on Direct Oral Anticoagulant: Systematic Review and Meta-Analysis.直接口服抗凝剂治疗期间钝性头部外伤后迟发性颅内出血：系统评价和荟萃分析。
J Am Coll Surg. 2021 Jun;232(6):1007-1016.e5. doi: 10.1016/j.jamcollsurg.2021.02.016. Epub 2021 Mar 22.
10
Thin blood. Risk of internal bleeding heightened with anticoagulant therapy.
JEMS. 2013 Sep;38(9):26-8.
Zotero 插件